Notably, the regional tau-PET uptake across biofluid staging groups was concordant with neurofibrillary pathology progression in AD [27], which might suggest that these classification schemes could be insightful in certain contexts, such as research settings. The gene discussed is MAPT; the disease is Alzheimer disease.